In fact, in response to a variety of stimulatory or inhibitory regimens in fetal lung explants or in the human adenocarcinoma H441 cell line, the levels of human SP-A protein and/or mRNA change significantly (70–73). The gene discussed is SFTPA1; the disease is adenocarcinoma.